Taiwanese Pharmaceuticals & Biotech Breakout Stocks

Results

3 new

Stocks where the price continues to rise after more than a year of consistent gains.

3 companies

Lin BioScience

Market Cap: NT$50.7b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

6696

NT$612.00

26.8%

335.6%

ACRO Biomedical

Market Cap: NT$13.2b

Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.

6748

NT$186.00

22.8%

375.1%

Great Novel Therapeutics Biotech & Medicals

Market Cap: NT$2.1b

Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.

7427

NT$49.10

22.9%

51.5%